Kidney function estimated by creatinine and cystatin C and adverse cardiovascular outcomes in patients with atrial fibrillation

J Intern Med. 2024 Nov 27. doi: 10.1111/joim.20036. Online ahead of print.

Adrian Schweigler^{1

2}, Elisa Hennings^{1

2}, Stefanie Aeschbacher^{1

2}, Désirée Carmine^{1

2}, Tobias Reichlin³, Nicolas Rodondi^{4

5}, Annina Stauber⁶, Peter Ammann⁷, Giorgio Moschovitis⁸, Lucy Bolt^{4

5}, Andrea Demarchi⁹, Andreas S Mueller⁶, Danielle Reneau², Michael Coslovsky^{2

10}, Christine S Zuern^{1

2}, Leo H Bonati¹¹, David Conen¹², Stefan Osswald^{1

2}, Michael Kühne^{1

2}, Philipp Krisai^{1

2}; Swiss‐AF Investigators

¹ Cardiology/ Electrophysiology Division, Department of Medicine, University Hospital Basel, Basel, Switzerland.
² Cardiovascular Research Institute Basel, University Hospital Basel, University of Basel, Basel, Switzerland.
³ Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
⁴ Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
⁵ Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
⁶ Department of Cardiology, Triemli Hospital Zurich, Zurich, Switzerland.
⁷ Department of Cardiology, Kantonsspital St Gallen, St Gallen, Switzerland.
⁸ Division of Cardiology, Ospedale Regionale di Lugano, Ente Ospedaliero Cantonale, Lugano, Switzerland.
⁹ Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano, Switzerland.
¹⁰ Clinical Trial Unit Basel, Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
¹¹ Department of Neurology and Stroke Center, University Hospital Basel, University of Basel, Basel, Switzerland.
¹² Health Research Institute, McMaster University, Hamilton, Ontario, Canada.

No abstract available

Keywords: atrial fibrillation; biomarker; cardiovascular risk; chronic kidney disease; cystatin C..

Publication types